In ACLF patients associated with severe sepsis, a therapeutic approach using a granulocyte colony-stimulating factor associated with darbepoetin seemed to improve one-year survival in patients diagnosed with decompensated cirrhosis [118,119]. This evidence concerns the gene CSF3 and Sepsis.